CRISPR Therapeutics AG

CRSPNASDAQ NMS - GLOBAL MARKET

Biotechnology

IPO 2016-10-19Country CHcrisprtx.com

$46.99

-0.79 (-1.65%)

Current Price

$46.99

Daily Change

-0.79 (-1.65%)

Volume

Prev Close

$47.78

Key Statistics

Market Cap

$4.53B

Enterprise Value

$4.75B

Shares Outstanding

96M

Beta

1.77

P/E (TTM)

Forward P/E

PEG Ratio

P/B

2.60

P/S

1,118.22

EV / EBITDA

14.25

EPS (TTM)

$-6.21

Dividend Yield

52-Week High

$78.48

52-Week Low

$44.12

Avg Volume (3M)

1.80M

Float

Financial Health

Revenue (TTM)

$4M

Gross Margin

Operating Margin

-15,754.20%

Net Margin

ROE

-30.88%

ROA

-24.54%

Debt / Equity

Current Ratio

13.32

Free Cash Flow

Earnings History

PeriodEPS EstimateActual EPSBeat / MissSurprise %
2026-03-31$-1.25$-1.28Miss-2.49%
2025-12-31$-1.18$-1.37Miss-16.44%
2025-09-30$-1.29$-1.17Beat+9.04%
2025-06-30$-1.45$-1.29Beat+11.24%

Analyst Ratings

Consensus · 32 analysts

Buy 19 (59%)Hold 13 (41%)Sell 0 (0%)

Insider Activity

Recent Buys

NameSharesPriceDate
Treco Douglas A+20,000$57.032025-08-06

Recent Sells

NameSharesPriceDate
Patel Naimish-3,786$55.622026-05-29
KASINGER JAMES R.-3,182$46.782026-03-23
Kulkarni Samarth-10,020$46.782026-03-23
Prasad Raju-3,708$46.782026-03-23
Patel Naimish-3,150$48.262026-03-16
Prasad Raju-4,021$48.262026-03-16